Q-Line Biotech SME IPO Details
Q-Line Biotech is a healthcare and biotechnology company engaged in the manufacturing and supply of diagnostic, pharmaceutical, and biotech-related products. Founded with a focus on quality healthcare solutions, the company serves hospitals, laboratories, and medical institutions through a customer-centric business model. It mainly operates across various Indian states while also exploring export opportunities. The company focuses on maintaining product quality, regulatory compliance, and expanding its presence in the growing healthcare sector.
IPO Review
IPO GMP
IPO Subscription Subscription
Stock Price
As the IPO is listed, here is the Live Share Price for Q-Line Biotech
IPO Summary
What is the Q-Line Biotech IPO Timetable?
Track the IPO schedule and key events.
| Event | Date | Day |
|---|---|---|
| IPO Open Date | 21 May, 2026 Thu | Thursday |
| IPO Close Date | 25 May, 2026 Mon | Monday |
| Basis of Allotment | 26 May, 2026 Tue | Tuesday |
| Refunds Initiated | 27 May, 2026 Wed | Wednesday |
| Credit to Demat | 27 May, 2026 Wed | Wednesday |
| Listing Date | 29 May, 2026 Fri | Friday |
What is the Q-Line Biotech IPO Lot Size?
Bidding in multiples of 400 shares.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 800 | ₹2,74,400 |
| Retail (Max) | 2 | 800 | ₹2,74,400 |
| HNI (Min) | 3 | 1200 | ₹4,11,600 |
About Q-Line Biotech
The company is promoted by Saurabh Garg along with Amita Garg and other promoter group members. Q-Line Biotech follows a business model focused on indigenous manufacturing, imports, distribution, and after-sales support for diagnostic instruments and consumables. The company emphasises affordable healthcare solutions under the “Make in India” initiative while investing in research, quality control, and technology-driven manufacturing to strengthen its position in the Indian diagnostic industry.
Objects of the Issue
| Issue Object | Estimate Amount |
|---|---|
Strengths & Risks
Strengths
- ✓ Strong presence in the diagnostic and IVD products industry across India.
- ✓ Wide product portfolio including biochemistry, molecular diagnostics, ELISA, and rapid test kits.
- ✓ Focus on indigenous manufacturing under the “Make in India” initiative.
- ✓ Experienced promoter leadership with healthcare industry expertise and nationwide distribution network.
- ✓ Strong emphasis on R&D, quality standards, and ISO-certified manufacturing processes.
Risks
- ⚠ Business depends heavily on the healthcare and diagnostics sector demand cycle.
- ⚠ High competition from established multinational diagnostic and medical device companies.
- ⚠ Regulatory changes in medical devices and diagnostic products may impact operations.
- ⚠ Dependence on continuous innovation and new product approvals for growth.
- ⚠ Any disruption in raw material supply or distributor network can affect business performance.
Company Financials
Summary of financial performance including revenue, profit, and debt levels will be populated here.
Promoters and Shareholding Details
| Particular | % Share |
|---|---|
| Promoter Holding Pre Issue | 96.77 |
| Promoter Holding Post Issue | -- |
Frequently Asked Questions
What is the GMP of Q-Line Biotech?
The current Grey Market Premium (GMP) of Q-Line Biotech is ₹ 108.
What is the Q-Line Biotech IPO Price Band?
The price band for Q-Line Biotech IPO is 343.
When is the Q-Line Biotech IPO Allotment?
The allotment date for Q-Line Biotech IPO is May 26, 2026.
How to check Q-Line Biotech IPO Allotment Status?
You can check the allotment status on the IPO Allotment Status page or on the registrar's website (Purva Sharegistry (India) Pvt.Ltd.).
Registrar
Purva Sharegistry (India) Pvt.Ltd.
Discussion 0
No comments yet
Be the first to share your thoughts!